Lista Florigio, Peragallo Mario Stefano, Biselli Roberto, De Santis Riccardo, Mariotti Sabrina, Nisini Roberto, D'Amelio Raffaele
Istituto di Scienze Biomediche della Difesa, Ispettorato Generale della Sanità Militare, Stato Maggiore della Difesa, 00184 Roma, Italy.
Centro Studi e Ricerche di Sanità e Veterinaria, Comando Logistico dell'Esercito, 00184 Roma, Italy.
Pathogens. 2023 Jun 23;12(7):868. doi: 10.3390/pathogens12070868.
In 1918 many countries, but not Spain, were fighting World War I. Spanish press could report about the diffusion and severity of a new infection without censorship for the first-time, so that this pandemic is commonly defined as "Spanish flu", even though Spain was not its place of origin. "Spanish flu" was one of the deadliest pandemics in history and has been frequently compared with the coronavirus disease (COVID)-19 pandemic. These pandemics share similarities, being both caused by highly variable and transmissible respiratory RNA viruses, and diversity, represented by diagnostics, therapies, and especially vaccines, which were made rapidly available for COVID-19, but not for "Spanish flu". Most comparison studies have been carried out in the first period of COVID-19, when these resources were either not yet available or their use had not long started. Conversely, we wanted to analyze the role that the advanced diagnostics, anti-viral agents, including monoclonal antibodies, and innovative COVID-19 vaccines, may have had in the pandemic containment. Early diagnosis, therapies, and anti-COVID-19 vaccines have markedly reduced the pandemic severity and mortality, thus preventing the collapse of the public health services. However, their influence on the reduction of infections and re-infections, thus on the transition from pandemic to endemic condition, appears to be of minor relevance. The high viral variability of influenza and coronavirus may probably be contained by the development of universal vaccines, which are not easy to be obtained. The only effective weapon still remains the disease prevention, to be achieved with the reduction of promiscuity between the animal reservoirs of these zoonotic diseases and humans.
1918年,许多国家(但不包括西班牙)正在进行第一次世界大战。西班牙媒体能够首次不受审查地报道一种新感染的传播情况和严重程度,因此这场大流行通常被定义为“西班牙流感”,尽管西班牙并非其起源地。“西班牙流感”是历史上最致命的大流行之一,经常被与冠状病毒病(COVID)-19大流行相比较。这些大流行有相似之处,都是由高度可变且可传播的呼吸道RNA病毒引起的;也有不同之处,体现在诊断、治疗,尤其是疫苗方面,COVID-19很快就有了可用的疫苗,但“西班牙流感”却没有。大多数比较研究是在COVID-19的第一阶段进行的,当时这些资源要么尚未可用,要么使用时间不长。相反,我们想分析先进的诊断方法、抗病毒药物(包括单克隆抗体)以及创新的COVID-19疫苗在疫情控制中可能发挥的作用。早期诊断、治疗和抗COVID-19疫苗显著降低了大流行的严重程度和死亡率,从而防止了公共卫生服务的崩溃。然而,它们对减少感染和再感染的影响,进而对从大流行向地方病状态转变的影响,似乎不太显著。流感和冠状病毒的高病毒变异性可能通过通用疫苗的研发来控制,但通用疫苗并不容易获得。唯一仍然有效的武器仍然是疾病预防,这要通过减少这些人畜共患病的动物宿主与人类之间的混杂来实现。